98%
921
2 minutes
20
Background: Acne is a chronic inflammatory skin disease affecting pilosebaceous unit. However, its specific mechanism remain incompletely understood.
Objectives: This study aims to identify and analyze the differential expression of serum exosomal miRNA in severe acne, revealing new insights into the pathogenesis of acne.
Methods: MiRNAs were extracted from serum exosomes of 15 patients with severe acne and 15 healthy controls. MiRNA libraries were constructed and sequenced using Illumina HiSeq 2500. The DESeq2R was applied to identify differentially expressed miRNAs. The candidate target genes were predicted using multiple miRNA databases. The DAVID database was used to enrich GO function and KEGG pathway analysis of target genes. Cytoscape3.10.0 was employed to construct a PPI interaction network and further screen hub genes. The most significantly differentially expressed miRNAs were validated using RT-qPCR detection.
Results: Small RNA-Seq analysis identified a total of 96 serum exosome miRNAs, with 33 up-regulated and 63 down-regulated. Target prediction across four miRNA databases identified 10,569 target genes. GO analysis showed that target genes were mainly enriched in transcriptional regulation, signal transduction and protein binding; KEGG analysis revealed enrichment in 160 pathways including PI3K-Akt and MAPK signaling pathway. Cytoscape 3.10.0 identified 7 hub genes: PIK3R1, PIK3CA, SRC, EGFR, JAK2, ERBB2, and IGF1R, along with 35 corresponding differentially expressed miRNAs. RT-qPCR results indicated a significant reduction in exosomal miR-124-3p levels in severe acne.
Conclusions: Serum exosomal miRNA expression in patients with severe acne significantly differed from that in healthy individuals. The exosomal miR-124-3p expression was markedly reduced in severe acne compared to healthy controls. Consequently, the increase of miR-124-3p expression may have potential therapeutic implications for severe acne.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230035 | PMC |
http://dx.doi.org/10.3389/fimmu.2025.1554811 | DOI Listing |
Arch Gynecol Obstet
September 2025
Department of Women's and Children's Health Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, L.Go Agostino Gemelli, 8, 00168, Rome, Italy.
Purpose: Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder affecting about 10% of reproductive-age women. Characterized by hyperandrogenism and ovulatory dysfunction, PCOS often involves metabolic features due to insulin resistance. Traditional treatment with combined oral contraceptive pills (COCP) effectively manages hyperandrogenism and menstrual irregularities.
View Article and Find Full Text PDFIndian J Dermatol
September 2025
From the Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, Spain.
Hidradenitis suppurativa (HS) significantly impacts patients' quality of life, particularly in major life-changing decisions (MLCDs) such as career, relationships, and lifestyle. This cross-sectional study involving 50 HS patients identifies critical socio-demographic and clinical factors, such as female sex, disease severity, and missed treatment opportunities, influencing MLCDs. Targeted interventions to mitigate these impacts are crucial for improving patient outcomes.
View Article and Find Full Text PDFArch Pharm (Weinheim)
September 2025
Universidad Espíritu Santo, Samborondón, Ecuador.
Despite notable advancements in conventional cancer therapies, challenges such as drug resistance, adverse effects, and high treatment costs remain significant obstacles. This situation calls for exploring new therapeutic options. One promising approach is drug repurposing, which uses existing medications with known effects to identify new anticancer agents.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Department of Dermatology, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Acne vulgaris (AV) is a common dermatological condition characterized by inflammatory and noninflammatory skin lesions. Isotretinoin (IOS), a systemic retinoid, is widely recognized for its efficacy in managing severe AV due to its potent anti-inflammatory and sebosuppressive properties. IOS interacts with nuclear receptors belonging to the steroid-thyroid hormone superfamily.
View Article and Find Full Text PDFBMJ Open
September 2025
Department of Social Medicine and Health Management, School of Public Health,Cheeloo College of Medicine, Shandong University, Jinan, China
Objectives: The presence of acne can significantly impact patients' health-related quality of life (HRQoL); however, the correlation between patient-reported HRQoL impairment and clinician-evaluated severity has been unclear. The objective of the study was to evaluate HRQoL in patients with different acne severity using generic, dermatology-specific and acne-specific instruments and investigate the correlation between clinical severity and HRQoL.
Design: Data for the cross-sectional survey were extracted from March 2017 to December 2018.